Precision BioSciences Presents Preclinical Data on PBGENE-HBV at Global Hepatitis Summit 2025 Introduction Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical-stage gene editing company known for its novel ARCUS® platform, has unveiled promising preclinical data supporting the use of repeat dosing…
ICON Integrates Medidata Clinical Data Studio to Enhance Clinical Trial Efficiency Introduction Medidata, a Dassault Systèmes brand and a global leader in clinical trial solutions, has announced that ICON plc, a leading clinical research organization (CRO), will be integrating the…
Omnipod® 5 RADIANT Trial Shows Significant Glycemic Improvements Following Direct Transition from MDI Insulet Corporation, a leader in tubeless insulin pump technology, has released groundbreaking results from its RADIANT clinical trial, which were presented at the 18th International Conference on…
Keysight Launches Photonic Designer: A Comprehensive Solution for Accurate Photonic Circuit Design Introduction to Photonic Designer Keysight Technologies, Inc. has introduced Photonic Designer, a groundbreaking photonic design automation (PDA) software solution tailored for photonics design engineers. This innovative tool aims…
City of Hope Launches Phase 1/2 Trial to Test Osteoporosis Medication for Early Type 1 Diabetes Treatment City of Hope®, one of the foremost cancer research and treatment centers in the U.S. and a top institution for diabetes research, has…
AM Batteries and TDK Collaborate to Advance Energy-Efficient Battery Manufacturing AM Batteries, a leader in dry battery electrode (DBE) technology, has entered into a joint development agreement with TDK Corporation, a global electronics leader. This collaboration aims to advance energy-efficient…
Synchron Unveils Chiral™: The World’s First Cognitive AI Brain Model Introduction to Chiral™ and Cognitive AI Synchron, a pioneering brain-computer interface (BCI) company, has unveiled Chiral™, the world’s first cognitive AI brain foundation model. This groundbreaking development marks the beginning…
Precision BioSciences Presents Promising Preclinical Data for PBGENE-DMD in Duchenne Muscular Dystrophy at 2025 MDA Conference Introduction to PBGENE-DMD and the DMD Challenge Precision BioSciences, Inc., a clinical-stage gene editing company, has announced the presentation of promising preclinical data for…
Cellares and Cabaletta Bio Successfully Complete Technology Adoption Program for Rese-cel Using Cell Shuttle™ Platform Cellares, the first Integrated Development and Manufacturing Organization (IDMO), has successfully concluded the Technology Adoption Program (TAP) for its innovative automated cell therapy manufacturing platform,…
Sapio Sciences Integrates NVIDIA BioNeMo to Streamline AI-Driven Drug Discovery Sapio Sciences, the science-aware™ lab informatics platform, has announced a significant advancement in the field of drug discovery with the integration of NVIDIA BioNeMo into its platform. This integration seamlessly…
PHC and Cyfuse Develop Breakthrough Technology for Commercializing 3D Cell Products PHC Corporation, a subsidiary of PHC Holdings Corporation, and Cyfuse Biomedical K.K. have announced a significant milestone in the field of regenerative and cell therapy. The two companies have…
Industry 4.0 Gains Traction Across Europe’s Manufacturing Sector The digital transformation of Europe’s manufacturing industry continues to accelerate, with Industry 4.0 initiatives making significant strides. A new research report by Information Services Group (ISG), a leading global technology research and…